Literature DB >> 1082444

T and CR+ lymphocyte profile in leprosy and the effect of treatment.

R Sher, G Holm, S H Kok, H J Koornhof, A Glover.   

Abstract

Thymus-derived lymphocytes (T lymphocytes) and complement receptor-bearing lymphocytes (CR+ lymphocytes) were estimated by using erythrocyte rosettes and erythrocyte-antibody-complement rosettes as markers in untreated lepromatous and untreated tuberculoid patients and in healthy controls. Treated lepromatous cases were also investigated. Ten cases of untreated lepromatous patients were reassessed 6 months or more after therapy commenced. A significant decrease in both percentages and absolute numbers of CR+ cells in the untreated lepromatous leprosy subjects was observed. This decrease showed a return to normal levels after treatment. The percentage of T cells in the untreated lepromatous cases was normal; however, the absolute numbers of T cells and the total lymphocyte count showed a significant decrease. After therapy, the T cell population was unchanged but the total number of lymphocytes increased significantly with treatment. The absolute number of T and CR+ cells was significantly less in the untreated than in the treated lepromatous patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082444      PMCID: PMC420573          DOI: 10.1128/iai.13.1.31-35.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Impaired delayed hypersensitivity in patients with lepromatous leprosy.

Authors:  D S Waldorf; J N Sheagren; J R Trautman; J B Block
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

2.  Evidence for circulating immune complexes in lepromatous leprosy.

Authors:  C J Moran; G Ryder; J L Turk; M F Waters
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

3.  Presence of C1q-reactive immune complexes in patients with leprosy.

Authors:  O Rojas-Espinosa; I Mendez-Navarrete; S Estrada-Parra
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

4.  Immunological significance of changes in lymph nodes across the leprosy spectrum.

Authors:  J L Turk; M F Waters
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

5.  In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors:  H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.

Authors:  W Boyle
Journal:  Transplantation       Date:  1968-09       Impact factor: 4.939

Review 7.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

8.  Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin.

Authors:  S H Han; R S Weiser; Y C Lin
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Oct-Dec

9.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  7 in total

1.  Hepatitis B antigen, hepatitis B antibody, and subtypes in leprosy.

Authors:  R Sher; M E Mackay; G M Macnab; S H Kok; H J Koornhof
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

2.  Isolation of human eosinophils and their lymphocyte-like rosetting properties.

Authors:  R Sher; A Glover
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

3.  Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats.

Authors:  T J Rogers; E Balish
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

4.  Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.

Authors:  J Touw; G L Stoner; A Belehu
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

5.  Mitogenic activity of two Brucella fractions for murine B lymphocytes.

Authors:  J P Vendrell; A Escande; A Cannat; M F Huguet; A Serre
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

6.  Polymorphonuclear cell function in the various polar types of leprosy and erythema nodosum leprosum.

Authors:  R Sher; R Anderson; A Glover; A A Wadee
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

7.  Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.

Authors:  E M Anders; K P McAdam; R F Anders
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.